Fetal Surveillance
Overview
Fetal surveillance is antepartum testing of fetal well-being. The nonstress test (NST) is the usual first-line, noninvasive screen for adequate oxygenation; the contraction stress test (CST) and biophysical profile (BPP) escalate when the NST is nonreactive. Key trap: the tests use opposite language — a REACTIVE NST is reassuring, but a POSITIVE CST is abnormal.
Indications
During — Monitoring
Interpretation
Reactive NST (≥32 wk): ≥2 accelerations of ≥15 bpm above baseline lasting ≥15 sec within 20 min. Before 32 weeks the threshold relaxes to 10 bpm × 10 sec. Nonreactive = criteria not met after 40 min including vibroacoustic stimulation — it warrants further evaluation, NOT immediate delivery and not by itself fetal distress.
NST vs CST vs BPP
NST
- What it measures
- FHR accelerations with fetal movement
- Reassuring result
- Reactive: ≥2 accels ≥15bpm × ≥15s / 20min
- Concerning result
- Nonreactive after 40 min
- Role
- First-line noninvasive screen
CST
- What it measures
- FHR response to uterine contractions
- Reassuring result
- Negative: no late decelerations
- Concerning result
- Positive: late decels with majority of contractions
- Role
- Escalation test; contraindicated in placenta previa
BPP
- What it measures
- 5 parameters: breathing, movement, tone, fluid, NST
- Reassuring result
- Score 8-10
- Concerning result
- Score ≤4
- Role
- Comprehensive when NST nonreactive
Patient Teaching
Clinical Pearl
NST: reactive is reassuring. CST: negative is normal. When the test name says "stress," flip your instinct — positive is the bad one.